Caricamento...
Metabolic consequences of oncogenic IDH mutations
Specific point mutations in isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) occur in a variety of cancers, including acute myeloid leukemia (AML), low-grade gliomas, and chondrosarcomas. These mutations inactivate wild-type enzymatic activity and convey neomorphic function to produce D-2-hydroxyglu...
Salvato in:
| Pubblicato in: | Pharmacol Ther |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4489982/ https://ncbi.nlm.nih.gov/pubmed/25956465 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pharmthera.2015.05.003 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|